---
$id: https://graph.org.ai/products/commodity/51111759
$type: Product
source: UNSPSC
code: "51111759"
title: "Piroxantrone"
class: "51111700"
classTitle: "Antineoplastic antibiotics"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Piroxantrone

**UNSPSC Code**: 51111759
**Class**: [Antineoplastic antibiotics](Antineoplastic antibiotics.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anthrapyrazole antibiotic with the molecular formula C21H25N5O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YL4TY9WH22, chemically known as anthra(1,9-cd)pyrazol-6(2h)-one, 5-((3-aminopropyl)amino)-7,10-dihydroxy-2-(2-((2-hydroxyethyl)amino)ethyl)- but generally known as piroxantrone, which bears US NIH Compound Identifier 5362372. European Medicines Agency schedules Piroxantrone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09935MIG. The term PIROXANTRONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). PIROXANTRONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule piroxantrone under HS 29339990 and SITC 51577. As of Q4 2014, PIROXANTRONE remains the US FDA Preferred Term for this commodity. Piroxantrone bears US NLM identifiers UMLS ID C0069736 and NCI Concept Code C1182. SMILES: OC1C2C3C([NH]N(C3CCC2NCCCN)CCNCCO)C2C1C(=O)C=CC2=O.

